Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial

(2013) Berit Rosche et al.   Trials

Trichuris suisova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response

(2012) C. D. Bourke et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients

(2011) F. Benzel et al.   JOURNAL OF HELMINTHOLOGY

Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study

(2011) JO Fleming et al.   Multiple Sclerosis Journal

Symptoms after Ingestion of Pig Whipworm Trichuris suis Eggs in a Randomized Placebo-Controlled Double-Blind Clinical Trial

(2011) Peter Bager et al.   PLoS One

Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?

(2010) D. Hesse et al.   EUROPEAN JOURNAL OF NEUROLOGY

Breakthrough disease during interferon-  therapy in MS: No signs of impaired biologic response

(2010) D. Hesse et al.   NEUROLOGY

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial

(2009) Peter Bager et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Helminth infections associated with multiple sclerosis induce regulatory B cells

(2008) Jorge Correale et al.   ANNALS OF NEUROLOGY